Tag Archives: Seikagaku

Genzyme Hyaluaronic acid products

In addition to earlier post, Genzyme filed another complaint against Seikagaku and Anika Therapeutics on infringement of 7,931,030 (expires on 20/12/2025). [Seikagaku] [Anika Therapeutics] Genzyme markets Synvisc and Synvisc One. Both are injectable elastic and viscous cross-linked HA gel approved in US.  Seikagaku received … Continue reading

Posted in Daily interesting IP news, Patent case | Tagged , , , | Leave a comment

Genzyme sues Seikagaku on 5,399,351

Genzyme sues Seikagaku on US patent 5399351 (Expiry: 21/03/2012) for Seikagaku’s Hyaluronic acid product (Gel-One). We may recall that Genzyme has sued Q-med on the same patent ‘ 351 and later Q-med/Medicis settles the law suit with Genzyme (Link). Genzyme … Continue reading

Posted in Patent case | Tagged , , , | 1 Comment